01 1Cipla
01 1CETIRIZINE DIHYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-03-25
Pay. Date : 2016-03-08
DMF Number : 15145
Submission : 2000-11-17
Status : Active
Type : II
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CETIRIZINE DIHYDROCHLORIDE USP, with a corresponding US DMF Number 15145.
Remarkably, this DMF maintains an Active status since its submission on November 17, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 25, 2016, and payment made on March 08, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
